Variables | Patients (n = 510) |
---|---|
Age (years) | 50.1 ± 11.2 |
Sex, n (%) | |
 Men | 449 (88.0%) |
 Women | 61 (12.0%) |
Etiology, n (%) | Â |
 Hepatitis B | 457 (89.6%) |
 Hepatitis C | 10 (2.0%) |
 Other | 43 (8.4%) |
ALT (U/L) | 36.5 ± 24.6 |
AST (U/L) | 39.2 ± 21.2 |
Albumin (g/L) | 39.7 ± 4.5 |
Total bilirubin (μmol/L) | 13.4 ± 5.2 |
Creatinine (μmol/L) | 70.5 ± 15.2 |
Platelet count (109/L) | 143.6 ± 72.5 |
INR | 1.1 ± 0.1 |
PT (s) | 13.1 ± 1.6 |
ICG-R15 (%) | 5.7 ± 4.6 |
Tumor size (cm) | 6.6 ± 3.7 |
Tumor number, n (%) | |
 1 | 447 (87.6%) |
 ≥ 2 | 63 (12.4%) |
Portal vein diameter (cm) | 1.2 ± 0.2 |
Splenic thickness (cm) | 4.0 ± 0.8 |
Varicosity, n (%) | |
 No | 437 (85.7%) |
 Mild | 43 (8.4%) |
 Moderate | 13 (2.5%) |
 Severe | 17 (3.3%) |
CSS, n (%) | |
 No/mild cirrhosis | 246 (48.2%) |
 Moderate cirrhosis | 169 (33.1%) |
 Severe cirrhosis | 95 (18.6%) |
Extent of hepatectomy, n (%) | |
 Major resection | 92 (18.0%) |
 Minor resection | 418 (82.0%) |
Intraoperative blood loss (ml) | 379.6 ± 378.9 |
Intraoperative RBC transfusion, n (%) | 88 (17.3%) |
Pathological stage, n (%) | |
 F0-F3 | 81 (15.9%) |
 F4A | 149 (29.2%) |
 F4B | 183 (35.9%) |
 F4C | 97 (19.0%) |
PHLF, n (%) | 59 (11.6%) |
90-day mortality, n (%) | 9 (1.8%) |